A novel clinician‐delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2)
Psycho-Oncology · 2023-12 · 32 (12) · 1930-1938
DOI: 10.1002/pon.6249 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Psycho-Oncology, online erschienen am 13.11.2023. Verfasst von Jia Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sydney Health Partners/Sydney Local Health District Implementation Grant, Sydney Breast Cancer Foundation.
Abstract (Originalsprache)
Objective
Fear of cancer recurrence (FCR) is highly prevalent, however there is no formal training for clinicians to address FCR. A novel brief clinician intervention to help patients manage FCR (Clinician Intervention to Reduce Fear of Recurrence (CIFeR)) was shown to be feasible, acceptable, and reduced FCR in breast cancer patients in a pilot study. We now aim to explore the barriers and facilitators of implementing CIFeR within routine oncology practice in Australia.
Methods
This multicentre, single‐arm Phase I/II implementation study recruited surgical, medical and radiation oncologists who treat women with early breast cancer. Participating clinicians completed online CIFeR training and were asked to use CIFeR for the next 6 months. Questionnaires were administered before (T0), immediately after (T1), then 3 (T2) and 6 months (T3) after training to assess confidence in addressing FCR and Proctor Implementation outcomes. The primary outcome was adoption at T2. Secondary outcomes were self‐efficacy in FCR management, acceptability, feasibility, costs, barriers and facilitators of implementation.
Results
Fifty‐two clinicians consented of whom 37 completed the CIFeR intervention training. Median age of participants was 41.5 (range 29–61), 73% were female and 51% were medical oncologists. The primary endpoint was met, with CIFeR adopted by 82%. Clinician intervention delivery took 7.4 min on average and was deemed acceptable, appropriate and feasible. Self‐efficacy in managing FCR improved significantly across all domains ( p < 0.001). Lack of time was the greatest barrier to routine CIFeR_2 implementation.
Conclusions
A structured brief, low‐cost clinician intervention to reduce FCR is useful, acceptable and improved self‐efficacy with FCR management. Fear of cancer recurrence training should be incorporated into communication skills training of oncologists and surgeons. Trial Registration Prospectively registered with the Australian New Zealand Clinical Trials Registry, ACTRN12621001697875. Trial Sponsor Chris O’Brien Lifehouse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, New South Wales, Australia.
- The University of Sydney, School of Psychology, Psycho-Oncology Cooperative Research Group, Sydney, New South Wales, Australia.
- St Vincent's Clinical School, University of New South Wales, Darlinghurst, New South Wales, Australia.
- The Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.
- Western Sydney University, Campbelltown, New South Wales, Australia.
ORCID-Profile: Phyllis Butow, Joanne Shaw, Anastasia Serafimovska
Förderung
- Sydney Health Partners/Sydney Local Health District Implementation Grant
- Sydney Breast Cancer Foundation
Zitieren
APA
Liu, J., He, S., Butow, P., Shaw, J., McHardy, C. J., Harris, G., Serafimovska, A., Butt, Z., & Beith, J. (2023). A novel clinician‐delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2). Psycho-Oncology, 32(12), 1930-1938. https://doi.org/10.1002/pon.6249
Vancouver
Liu J, He S, Butow P, Shaw J, McHardy CJ, Harris G, et al. A novel clinician‐delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2). Psycho-Oncology. 2023;32(12):1930-1938. doi:10.1002/pon.6249
BibTeX
@article{Liu2023,
author = {Liu, Jia and He, Sharon and Butow, Phyllis and Shaw, Joanne and McHardy, Christopher John and Harris, Georgia and Serafimovska, Anastasia and Butt, Zoe and Beith, Jane},
title = {A novel clinician‐delivered intervention to reduce fear of recurrence in breast cancer survivors: Results from a Phase I/II implementation study (CIFeR_2)},
journal = {Psycho-Oncology},
year = {2023},
volume = {32},
number = {12},
pages = {1930--1938},
doi = {10.1002/pon.6249}
}
EUVIMED